Dipali Dipali Profile

Meticulous Research®—a leading global market research company, published a research report titled, “HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography – Global Forecast to 2029”.
According to this latest publication from Meticulous Research®, the global HLA typing market is projected to grow at a CAGR of 5.6% during the forecast period to reach $1.9 billion by 2029. The high growth of the HLA typing market is attributed to the increasing number of organ transplants and technological advancements in HLA typing. Moreover, increasing awareness about organ donations is creating growth opportunities for the global HLA typing market. However, the high costs of molecular techniques related to HLA typing limit the market growth. Additionally, the shortage of organs for transplantation poses a challenge to this market's growth.
Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5311
HLA Typing Market: Future Outlook
The global HLA typing market is segmented by Product (Instruments, Consumables, Software & Services), Technology (Molecular technologies [PCR-based Molecular Techniques {Sequence-specific Primers, Sequence-specific Oligonucleotide, and Other PCR PCR-based Molecular Techniques}, Sequencing-based Molecular Technologies {Sanger Sequencing, Next Generation Sequencing, Pyrosequencing}, DNA Microarray], Non-molecular Technologies), Application (Diagnostics [Donor Recipient Cross-matching, Transfusion Therapy, and Other Diagnostics Applications], Research), End User (Diagnostics Labs, Hospital & Transplant Centers, Academic & Research Institutes) and Geography. The study also evaluates industry competitors and analyzes the regional and country markets.
Based on product, in 2022, the consumables segment is estimated to account for the largest share of the HLA typing market. The large share of this segment is attributed to the growing applications of molecular assay techniques in HLA typing, the growing adoption of molecular diagnostic techniques in research studies, increasing emphasis on effective and early patient profiling for organ transplantation, and the rising number of organ transplantations.
Based on technology, in 2022, the molecular technologies segment is estimated to account for the largest share of the HLA typing market. Factors contributing to the large share of this segment include the advancements in molecular assays and the benefits of molecular techniques over non-molecular techniques. Molecular assays offer low turnaround times, multi-sample study capabilities, high procedural efficacy, and real-time sample analysis, increasing the demand for molecular assays compared to non-molecular assays.
Speak to Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5311
Based on application, in 2022, the diagnostics segment is estimated to account for the largest share of the HLA typing market. The increasing use of HLA typing in disease diagnosis and pathogenesis and the growing incidences of infectious and chronic diseases are the factors expected to propel the growth of this segment. The burden of infectious and non-infectious diseases is rising globally. For instance, according to the International Agency for Research on Cancer, the number of new cancer cases is estimated to increase by 59.2% from 2020 to 2040 in Asia and 21% from 2020 to 2040 in Europe. Thus, high disease prevalence contributes to the growth of this segment.
Based on end user, in 2022, the diagnostic laboratories segment is expected to account for the largest share of the HLA typing market. The diagnostic laboratories carry out the maximum number of HLA typing procedures. In most countries, hospitals are outsourcing their diagnostic capabilities. Therefore, although HLA typing is preferred to be carried out in the transplant facility, it is ultimately carried out in the diagnostic centers due to outsourcing. In addition, diagnostic centers can also carry out the pathogenesis of infectious diseases, contributing to the large share of this segment in the HLA typing market.
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
Based on geography, in 2022, North America is expected to dominate the global HLA typing market, followed by Europe and Asia-Pacific. The high prevalence of cancer and autoimmune diseases, the high number of organ transplants, and government funding for HLA and killer cell immunoglobulin-like receptors (KIR) for immune-mediated diseases support the growth of the North American HLA typing market.
Key Players:
The key players operating in the global HLA typing market are Thermo Fisher Scientific Inc. (U.S.), Bio-rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Genome Diagnostics B.V. (GenDx) (Netherlands), Illumina, Inc. (U.S.), CareDx (U.S.), Immucor Inc. (U.S.), TBG Diagnostics Limited (Australia), BAG Diagnostic GmbH (Germany), Omixon Inc. (Hungary), Luminex Corporation (U.S.), inno-train Diagnostik GmbH (Germany), Pacific Biosciences of California, Inc. (U.S.), and Fujirebio Holdings, Inc. (Japan).
Quick Buy: https://www.meticulousresearch.com/Checkout/76618224
Key questions answered in the report-
• What is the current value of revenue generated by HLA typing products across the globe?
• At what rate is the demand for global HLA typing products projected to grow for the next 5-7 years?
• What is the historical market size and growth rate for HLA typing across the globe?
• What are the major factors impacting the growth of this market at the global and regional levels? What are major opportunities for existing market players and new entrants in the market?
• What impact does the current COVID-19 pandemic have on the HLA typing market at various levels in the value chain?
• Which segments in terms of the product, technology, application, and end user are creating the major traction for the vendors in this market?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the global HLA typing market?
• Who are the major players in the global HLA typing market? And what are their specific instruments/consumables/software & services in the HLA typing industry?
• What recent developments have taken place in global HLA typing, and how these strategic developments are creating a global impact in this market?
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research sPvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research